These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29105850)
21. [Efficacy of a multidisciplinary team for preventing hospital-acquired invasive aspergillosis: five years' experience]. Etancelin P; Silly S; Merle V; Bonmarchand G; Richard JC; Vannier JP; Nouvellon M Pathol Biol (Paris); 2009 Feb; 57(1):71-5. PubMed ID: 19157722 [TBL] [Abstract][Full Text] [Related]
22. Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia). Gheith S; Ranque S; Bannour W; Ben Youssef Y; Khelif A; Ben Said M; Njah M; Saghrouni F Mycoses; 2015 Jun; 58(6):337-42. PubMed ID: 25809008 [TBL] [Abstract][Full Text] [Related]
23. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Weems JJ; Davis BJ; Tablan OC; Kaufman L; Martone WJ Infect Control; 1987 Feb; 8(2):71-5. PubMed ID: 3470268 [TBL] [Abstract][Full Text] [Related]
24. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. Alberti C; Bouakline A; Ribaud P; Lacroix C; Rousselot P; Leblanc T; Derouin F; J Hosp Infect; 2001 Jul; 48(3):198-206. PubMed ID: 11439007 [TBL] [Abstract][Full Text] [Related]
25. Invasive aspergillosis in children with acute leukemia at a resource-limited oncology center. Jain S; Kapoor G J Pediatr Hematol Oncol; 2015 Jan; 37(1):e1-5. PubMed ID: 24686246 [TBL] [Abstract][Full Text] [Related]
26. Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital. Chan TS; Marcella SW; Gill H; Hwang YY; Kwong YL J Med Econ; 2016; 19(1):77-83. PubMed ID: 26366612 [TBL] [Abstract][Full Text] [Related]
27. Risk of invasive fungal infections during hospital construction: how to minimize its impact in immunocompromised patients. Alvarez-Moreno CA; Combariza JF Curr Opin Infect Dis; 2019 Aug; 32(4):322-329. PubMed ID: 31157630 [TBL] [Abstract][Full Text] [Related]
28. Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis. Herbrecht R; Rajagopalan S; Danna R; Papadopoulos G Curr Med Res Opin; 2010 Oct; 26(10):2457-64. PubMed ID: 20822354 [TBL] [Abstract][Full Text] [Related]
29. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. Klimowski LL; Rotstein C; Cummings KM Infect Control Hosp Epidemiol; 1989 Jul; 10(7):299-305. PubMed ID: 2663973 [TBL] [Abstract][Full Text] [Related]
30. Nosocomial aspergillosis and building construction. Haiduven D Med Mycol; 2009; 47 Suppl 1():S210-6. PubMed ID: 18654924 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients. Balogh J; Gordon Burroughs S; Boktour M; Patel S; Saharia A; Ochoa RA; McFadden R; Victor DW; Ankoma-Sey V; Galati J; Monsour HP; Fainstein V; Li XC; Grimes KA; Gaber AO; Aloia T; Ghobrial RM Liver Transpl; 2016 Feb; 22(2):163-70. PubMed ID: 26515643 [TBL] [Abstract][Full Text] [Related]
35. The epidemiology and prevention of invasive aspergillosis. Manuel RJ; Kibbler CC J Hosp Infect; 1998 Jun; 39(2):95-109. PubMed ID: 9651854 [TBL] [Abstract][Full Text] [Related]